Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomaras

Showing results (361-370 of 525) with videos related to

Pageof 53
Sort By:
Frontiers in Immunology|December 21, 2023
Multivariate analysis of FcR-mediated NK cell functions identifies unique clustering among humans and rhesus macaquesMarina Tuyishime, Rachel L Spreng, Brady Hueber, et al.
Biorxiv : the Preprint Server for Biology|January 5, 2021
Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primatesKevin O Saunders, Norbert Pardi, Robert Parks, et al.
The Lancet. HIV|October 6, 2023
Safety, tolerability, pharmacokinetics, and immunological activity of dual-combinations and triple-combinations of anti-HIV monoclonal antibodies PGT121, PGDM1400, 10-1074, and VRC07-523LS administered intravenously to HIV-uninfected adults: a phase 1 randomised trialMagdalena E Sobieszczyk, Sharon Mannheimer, Carmen A Paez, et al.
Ebiomedicine|September 30, 2022
Baseline host determinants of robust human HIV-1 vaccine-induced immune responses: A meta-analysis of 26 vaccine regimensYunda Huang, Yuanyuan Zhang, Kelly E Seaton, et al.
Plos Pathogens|June 4, 2021
Structural and genetic convergence of HIV-1 neutralizing antibodies in vaccinated non-human primatesFangping Cai, Wei-Hung Chen, Weimin Wu, et al.
Frontiers in Big Data|July 2, 2021
Comprehensive Data Integration Approach to Assess Immune Responses and Correlates of RTS,S/AS01-Mediated Protection From Malaria Infection in Controlled Human Malaria Infection TrialsWilliam Chad Young, Lindsay N Carpp, Sidhartha Chaudhury, et al.
Immunohorizons|September 16, 2024
Probing Dermal Immunity to Mycobacteria through a Controlled Human Infection ModelE Chandler Church, Emma Bishop, Andrew Fiore-Gartland, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 30, 2013
DNA and virus particle vaccination protects against acquisition and confers control of viremia upon heterologous simian immunodeficiency virus challengeVainav Patel, Rashmi Jalah, Viraj Kulkarni, et al.
Plos One|August 23, 2011
A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204)Gavin J Churchyard, Cecilia Morgan, Elizabeth Adams, et al.
Journal of Virology|August 13, 2011
Primary infection by a human immunodeficiency virus with atypical coreceptor tropismChunlai Jiang, Nicholas F Parrish, Craig B Wilen, et al.
Pageof 53

Showing results (361-370 of 525) with videos related to

Sort By:
Pageof 53
Frontiers in Immunology|December 21, 2023
Multivariate analysis of FcR-mediated NK cell functions identifies unique clustering among humans and rhesus macaquesMarina Tuyishime, Rachel L Spreng, Brady Hueber, et al.
Biorxiv : the Preprint Server for Biology|January 5, 2021
Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primatesKevin O Saunders, Norbert Pardi, Robert Parks, et al.
The Lancet. HIV|October 6, 2023
Safety, tolerability, pharmacokinetics, and immunological activity of dual-combinations and triple-combinations of anti-HIV monoclonal antibodies PGT121, PGDM1400, 10-1074, and VRC07-523LS administered intravenously to HIV-uninfected adults: a phase 1 randomised trialMagdalena E Sobieszczyk, Sharon Mannheimer, Carmen A Paez, et al.
Ebiomedicine|September 30, 2022
Baseline host determinants of robust human HIV-1 vaccine-induced immune responses: A meta-analysis of 26 vaccine regimensYunda Huang, Yuanyuan Zhang, Kelly E Seaton, et al.
Plos Pathogens|June 4, 2021
Structural and genetic convergence of HIV-1 neutralizing antibodies in vaccinated non-human primatesFangping Cai, Wei-Hung Chen, Weimin Wu, et al.
Frontiers in Big Data|July 2, 2021
Comprehensive Data Integration Approach to Assess Immune Responses and Correlates of RTS,S/AS01-Mediated Protection From Malaria Infection in Controlled Human Malaria Infection TrialsWilliam Chad Young, Lindsay N Carpp, Sidhartha Chaudhury, et al.
Immunohorizons|September 16, 2024
Probing Dermal Immunity to Mycobacteria through a Controlled Human Infection ModelE Chandler Church, Emma Bishop, Andrew Fiore-Gartland, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 30, 2013
DNA and virus particle vaccination protects against acquisition and confers control of viremia upon heterologous simian immunodeficiency virus challengeVainav Patel, Rashmi Jalah, Viraj Kulkarni, et al.
Plos One|August 23, 2011
A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204)Gavin J Churchyard, Cecilia Morgan, Elizabeth Adams, et al.
Journal of Virology|August 13, 2011
Primary infection by a human immunodeficiency virus with atypical coreceptor tropismChunlai Jiang, Nicholas F Parrish, Craig B Wilen, et al.
Pageof 53